Akebia scrapes together $85M war chest to commercialize vada as PDUFA date looms

With its PDUFA date looming at the end of March, Akebia has revised its commercialization deal with Vifor, injecting a quick $85 million into the biotech to help launch the anemia drug vadadustat in style.